不同负压创面治疗参数对人断层皮片自体移植物的早期影响
研究以6例人离体皮肤制备的断层皮片为对象,比较-75 mmHg、-125 mmHg及无压力对照处理3小时后的基因表达差异。结果显示负压治疗可上调FGFR1、ET-1及22种角蛋白基因,且-125 mmHg组促炎基因S100A8和TNC分别上调8.8倍和9.1倍,而-75 mmHg组纤维蛋白原基因上调。提示-75 mmHg早期炎症反应更轻。
要点
- 负压治疗3小时即可引起人断层皮片基因表达显著改变,共95个基因转录差异。
- -125 mmHg组促炎基因S100A8和TNC分别上调8.8倍和9.1倍,-75 mmHg组则下调。
- -75 mmHg组纤维蛋白原γ链和α链基因较-125 mmHg组分别上调log2倍数-7.9和-7.4。
核心结论
- 负压创面治疗可能改善细胞迁移、增殖和血管生成,且-75 mmHg在早期比-125 mmHg炎症更轻、纤维蛋白原产生更多。
研究设计与样本
- 实验研究,采用6例人择期手术多余皮肤制备0.012英寸断层皮片,分别给予-75 mmHg(n=4)、-125 mmHg(n=4)、无压力对照(n=4)及无海绵无压力对照(n=6)处理3小时,行RNAseq并用免疫组化验证。
主要发现
- 所有处理组间共95个显著基因转录差异。
- 负压治疗显著上调FGFR1、ET-1和22种角蛋白基因表达。
- -75 mmHg与-125 mmHg组间有19个显著基因改变。
- 促炎基因S100A8和TNC在-125 mmHg组分别上调8.8倍和9.1倍,在-75 mmHg组下调。
- 纤维蛋白原γ链和α链基因在-125 mmHg组下调、-75 mmHg组上调,组间log2倍数变化分别为-7.9和-7.4。
临床怎么用
- 结果提示-75 mmHg可能在负压治疗早期减少炎症反应并增加纤维蛋白原产生,或有助于减轻患者疼痛不适并缩短治疗时间。
局限性
- 研究仅观察离体人皮肤断层皮片负压处理3小时的早期基因表达变化,样本量小,临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over 6.5 million people in the United States suffer from traumatic, burn, acute, and chronic wounds yearly. When reconstruction is required, split and full-thickness autografts are a first line of treatment intervention. Negative pressure wound therapy (NPWT) is gaining traction as an adjunct modality to improve graft survival, yet the specifics on what settings to apply topically over the graft is unsubstantiated and associated with morbidities. This study was performed in an effort to understand initial changes in wound and graft healing with a long-term goal of surface pressure optimization. Excess skin from elective procedures from six human subjects was trimmed to 0.012 inch in order represent a split-thickness autografts. These grafts were treated continuously with either -75 mm Hg (n = 4), -125 mm Hg (n = 4), or no pressure (n = 4) for 3 hours. Six skin grafts were treated with no sponge or pressure control (n = 6). RNAseq was performed on all treatment groups and compared with no pressure control. Significant gene expression changes with a subset focusing on inflammatory, cellular/extracellular matrix proliferation and angiogenic mediators and having greater than 2-fold were confirmed with immunohistochemistry staining. There are 95 significant gene transcription differences among all treatment groups. NPWT leads to significantly increased gene expression of FGFR1, ET-1, and 22 Keratin proteins. Between -75 and -125 mm Hg groups, there are 19 significant gene changes. Proinflammatory genes S100A8 and Tenacin C (TNC) demonstrate an 8.8- and 9.1-fold change, respectively, and is upregulated in -125 mm Hg group and downregulated in -75 mm Hg group. Fibrinogen genes fibrinogen gamma chain and fibrinogen alpha chain had respective log2-fold changes of -7.9 and -7.4 change between treatment groups and were downregulated in -125 mm Hg group and upregulated in -75 mm Hg group. There are varying effects of surface pressures on human split-thickness autografts during the imbibition time period. NPWT may improve cellular migration, proliferation, and angiogenesis over controls. Human skin grafts respond differently to -125 and -75 mm Hg within 3 hours of NPWT treatment. The results suggest -75 mm Hg leads to less inflammation and increased fibrinogen production compared with the -125 mm Hg group, at least initially. Reducing "time to heal" with NPWT is critical to successful outcomes and quality of life within young patients who often experience pain/discomfort when treated at the current standard pump settings. The results from this study and continued investigation may quickly translate to the clinical setting by finding the ideal pressure setting utilized in an effort to reduce NPWT length of treatment, improve patient comfort, satisfaction, and psychosocial well-being.
引用
- Rapp SJ, Dershem V, Zhang X, et al. Varying Negative Pressure Wound Therapy Acute Effects on Human Split-Thickness Autografts. J Burn Care Res. 2020. PMID: 31420676. doi:10.1093/jbcr/irz122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。